scholarly article | Q13442814 |
P50 | author | Fariborz Ghaffarpasand | Q38329634 |
Bahram Aminmansour | Q64214609 | ||
Masih Saboori | Q79915722 | ||
P2093 | author name string | Majid Rezvani | |
Ali Asnaashari | |||
Parisa Abdollahzadeh | |||
Seyed Mohammad Amin Noorian | |||
P2860 | cites work | The role of the cytoskeleton in cell body enlargement, increased nuclear eccentricity and chromatolysis in axotomized spinal motor neurons | Q21262945 |
Steroids for acute spinal cord injury | Q24203854 | ||
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials | Q24273391 | ||
Progesterone receptors: form and function in brain | Q28274391 | ||
Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate | Q28578932 | ||
Review of current evidence for apoptosis after spinal cord injury. | Q34076434 | ||
Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? | Q34284874 | ||
Give progesterone a chance | Q34319455 | ||
From basics to clinical: a comprehensive review on spinal cord injury | Q34387405 | ||
Pharmacological treatment of acute spinal cord injury: how do we build on past success? | Q34390497 | ||
Stimulating regeneration in the damaged spinal cord. | Q34470109 | ||
Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats | Q34489489 | ||
Very early administration of progesterone for acute traumatic brain injury. | Q35001801 | ||
Cell death in models of spinal cord injury | Q35002711 | ||
Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling | Q35918601 | ||
Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group | Q36529408 | ||
Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury | Q36973541 | ||
Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone | Q37260870 | ||
Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. | Q37422665 | ||
Progesterone and the spinal cord: good friends in bad times | Q37687772 | ||
The current role of steroids in acute spinal cord injury | Q38085979 | ||
Therapeutic effects of progesterone in animal models of neurological disorders. | Q38138132 | ||
Effect of gender on recovery after spinal cord injury | Q38170001 | ||
Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection | Q38246676 | ||
Activation of MAPKs by 1alpha,25(OH)2-Vitamin D3 and 17beta-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors | Q40188387 | ||
Progesterone neuroprotection in spinal cord trauma involves up-regulation of brain-derived neurotrophic factor in motoneurons | Q40428940 | ||
A clinical trial of progesterone for severe traumatic brain injury | Q41706401 | ||
Systemic administration of 17beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats | Q42626065 | ||
Cellular basis for progesterone neuroprotection in the injured spinal cord. | Q43951433 | ||
Progesterone production and actions in the human central nervous system and neurogenic tumors | Q44204085 | ||
Neuroprotective effects of progesterone in spinal cord ischemia in rabbits. | Q45240308 | ||
Effects of progesterone on experimental spinal cord injury | Q48318907 | ||
Gonadal steroid regulation of growth-associated protein GAP-43 mRNA expression in axotomized hamster facial motor neurons | Q48601162 | ||
The international standards booklet for neurological and functional classification of spinal cord injury. American Spinal Injury Association. | Q53385067 | ||
Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury | Q60683537 | ||
Transsynaptic degeneration of motoneurones caudal to spinal cord lesions | Q69597447 | ||
Steroid hormones protect spinal cord neurons from glutamate toxicity | Q72232866 | ||
Estradiol and progesterone synthesis in human placenta is stimulated by calcitriol | Q79674212 | ||
Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma | Q87122833 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vitamin | Q34956 |
vitamin D | Q175621 | ||
placebo | Q269829 | ||
P304 | page(s) | 272-280 | |
P577 | publication date | 2016-02-01 | |
P1433 | published in | The journal of spinal cord medicine : JSCM | Q26853939 |
P1476 | title | Effects of progesterone and vitamin D on outcome of patients with acute traumatic spinal cord injury; a randomized, double-blind, placebo controlled study | |
P478 | volume | 39 |
Q49598739 | A novel therapeutic approach for treatment of catamenial epilepsy |
Q58599809 | Effectiveness of two vitamin D repletion protocols on the vitamin D status of adults with a recent spinal cord injury undergoing inpatient rehabilitation: a prospective case series |
Q60950873 | Neuroprotective role of vitamin D in primary neuronal cortical culture |
Q38958818 | Vitamin D and spinal cord injury: should we care? |
Search more.